Skip to content

Transcutaneous electrical acupoint stimulation in the prevention of postdischarge nausea and vomiting in ambulatory surgery patients

Transcutaneous electrical acupoint stimulation in the prevention of postdischarge nausea and vomiting in ambulatory surgery patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083780
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postdischarge nausea and vomiting

Interventions

experimental group:From 30 minutes before surgery to leaving the PACU, wear a transcutaneous acupoint electrical stimulation wristband to continuously stimulate bilateral Neiguan acupoints. The stimul
control group:From 30 minutes before surgery to leaving the PACU, wear a transcutaneous acupoint electrical stimulation wristband that is not turned on.

Sponsors

The First Affiliated Hospital of Yangtze University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Ambulatory Laparoscopic Hysterectomy under General Anesthesia; (2) Age: 18-70 years, BMI: 15-40 kg/m², ASA Classification: I-II; (4) No significant impairment of organ function; (5) Capable of understanding, signing an Informed Consent, and cooperating with intervention and assessment.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating patients; (2) Contraindications to TEAS, such as skin allergies, broken skin at test points, infection or itching, implanted pacemakers; (3) Patients with preoperative pain, central analgesic drugs, opioid addiction and dependence; (4) Use of glucocorticoids, opioids, or antiemetics within 24 hours before surgery; (5) Local skin infection; (6) Patients with upper or lower limb nerve damage; (7) Participation in other similar clinical studies within 3 months before entering this study; (8) History of central nervous system disease, mental illness, or language communication disorder.

Design outcomes

Primary

MeasureTime frame
The incidence of postdischarge nausea and vomiting within 24 hours after surgery.;

Secondary

MeasureTime frame
The incidence of nausea;The incidence of vomiting;Severity of nausea;Severity of vomiting;Pain scores;Use of postoperative antiemetics;Adverse Reactions of TEAS;Quality of Recovery rating;Treatment satisfaction;

Countries

China

Contacts

Public ContactWei Xu

The First Affiliated Hospital of Yangtze University

weixumedical@163.com+86 181 6316 8576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026